Warwick Ventures Licensing Opportunities - School of Life Sciences
Rapid diagnostic test for SARS-CoV-2
Coronavirus diagnostics currently require centralised facilities and collection/distribution of swabs and results are ‘next day’. A new diagnostic tool being developed by the University of Warwick and its partner Iceni Diagnostics may allow on-the-spot detection of Coronavirus infection, without facilities using a simple disposable device.
More details: Rapid diagnostic test for SARS-CoV-2
Contact: Dr James Lapworth, Warwick Innovations email: j.lapworth@warwick.ac.uk
IVF pre-implantation screening method
A team at the University of Warwick has developed a new screening test that potentially provides an accurate and noninvasive method for assessing embryos during IVF treatment, prior to implantation.
More details: IVF pre-implantation screening method
Contact: Dr Suzanna Wood, Business Development Manager, Warwick Ventures. Tel: +44 (0)24 765 75490; email: s.k.wood@warwick.ac.uk
Increased Epigenetic Variation in Plants
A team at the University of Warwick has developed technology to increase the epigenetic variety of plants without the usual undesired side effects. The novel strategy allows a much greater range of epigenetic and phenotypic differences to be introduced than was previously possible.
More details: Increased epigenetic variation in plants
Contact: Dr Suzanna Wood, Business Development Manager, Warwick Ventures. Tel: +44 (0)24 765 75490; email: s.k.wood@warwick.ac.uk